The primary prevention of coronary heart disease in women

New England Journal of Medicine

Volumn 332, Issue 26, 1995, Pages 1758-1766

  Rich Edwards, Janet W ^a   Manson, Joann E ^a   Hennekens, Charles H ^a   Buring, Julie E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ALCOHOL; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; BETA CAROTENE; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT;

CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; HUMAN; REVIEW; RISK FACTOR; ALCOHOL CONSUMPTION; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; ESTROGEN DEFICIENCY; HEART INFARCTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; OBESITY; ORAL DRUG ADMINISTRATION; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING CESSATION; SYSTOLIC HYPERTENSION;

ANTIOXIDANTS; ASPIRIN; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029012215     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199506293322607     Document Type: Review

References (147)

1. National Center for Health Statistics. Vital statistics of the United States, 1989. Vol. II. Mortality. Part A. Washington, D.C.: Government Printing Office, 1993. (DHHS publication no. (PHS) 93-1101.)
2. —1993 Heart and stroke facts statistics. Dallas: American Heart Association, 1992.
3. Higgins M, Thom T Trends in CHD in the United States. Int J Epidemiol 1989; 19: Suppl 1: S58-S66
4. Manson JE, Tosteson H, Ridker PM, The primary prevention of myocardial infarction. N Engl J Med 1992; 326: 1406-1416
5. Causal inference in epidemiology. In: Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986:14.
6. Willett WC, Green A, Stampfer MJ, Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303-1309
7. LaCroix AZ, Lang J, Scherr P, Smoking and mortality among older men and women in three communities. N Engl J Med 1991; 324: 1619-1625
8. Rosenberg L, Palmer JR, Shapiro S Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990; 322: 213-217
9. Dorr AE, Gundersen K, Schneider JC Jr, Spencer TW, Martin WB Colestipol hydrochloride in hypercholesterolemic patients -- effect on serum cholesterol and mortality. J Chronic Dis 1978; 31: 5-14
10. Frantz ID Jr, Dawson EA, Ashman PL, Test of effect of lipid lowering by diet on cardiovascular risk: the Minnesota Coronary Survey. Arteriosclerosis 1989; 9: 129-135
11. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153: 578-581
12. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264
13. Lew EA, Garfinkel L Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32: 563-576
14. Hubert HB, Feinleib M, McNamara PM, Castelli WP Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977
15. Manson JE, Colditz GA, Stampfer MJ, A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889
16. Brunner D, Manelis G, Modan M, Levin S Physical activity at work and the incidence of myocardial infarction, angina pectoris and death due to ischemic heart disease: an epidemiological study in Israeli collective settlements (kibbutzim). J Chronic Dis 1974; 27: 217-233
17. Salonen JT, Puska P, Tuomilehto J Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in eastern Finland. Am J Epidemiol 1982; 115: 526-537
18. Lapidus L, Bengtsson C Socioeconomic factors and physical activity in relation to cardiovascular disease and death: a 12 year follow up of participants in a population study of women in Gothenberg, Sweden. Br Heart J 1986; 55: 295-301
19. Magnus K, Matroos A, Strackee J Walking, cycling, or gardening, with or without seasonal interruption, in relation to acute coronary events. Am J Epidemiol 1979; 110: 724-733
20. Scragg R, Stewart A, Jackson R, Beaglehole R Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. Am J Epidemiol 1987; 126: 77-85
21. Rosenberg L, Slone D, Shapiro S, Kaufman DW, Miettinen OS, Stolley PD Alcoholic beverages and myocardial infarction in young women. Am J Public Health 1981; 71: 82-85
22. Klatsky AL, Friedman GD, Siegelaub AB Alcohol consumption before myocardial infarction: results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med 1974; 81: 294-301
23. Petitti DB, Wingerd J, Pellegrin F, Ramcharan S Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA 1979; 242: 1150-1154
24. Gordon T, Kannel WB Drinking habits and cardiovascular disease: the Framingham Study. Am Heart J 1983; 105: 667-673
25. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988; 319: 267-273
26. Boston Collaborative Drug Surveillance Group. Regular aspirin intake and acute myocardial infarction. BMJ 1974; 1: 440-443
27. Manson JE, Stampfer MJ, Colditz GA, A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991; 266: 521-527
28. Paganini-Hill A, Chao A, Ross RK, Henderson BE Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 1989; 299: 1247-1250
29. Hammond EC, Garfinkel L Aspirin and coronary heart disease: findings of a prospective study. BMJ 1975; 2: 269-271
30. Manson JE, Stampfer MJ, Willett WC, A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 1991; 84: Suppl II: II-546 abstract.
31. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449
32. Stampfer MJ, Colditz GA Estrogen replacement therapy and coronary heart disease: quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63
33. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199-208
34. Reducing the health consequences of smoking: 25 years of progress: a report of the Surgeon General, 1989. Rockville, Md.: Department of Health and Human Services, 1989. (DHHS publication no. (CDC) 89-8411.)
35. Surveillance for selected tobacco-use behaviors -- United States, 1900-1994. MMWR Morb Mortal Wkly Rep 1994; 43: 1-43
36. Palmer JR, Rosenberg L, Shapiro S “Low yield” cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 1989; 320: 1569-1573
37. La Rosa JC, Hunninghake D, Bush D, The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol and coronary heart disease: a joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation 1990; 81: 1721-1733
38. Wenger NK Exclusion of the elderly and women from coronary trials: is their quality of care compromised? JAMA 1992; 268: 1460-1461
39. Froom J, Froom P “Prudence” in disease prevention. J Clin Epidemiol 1991; 44: 1127-1130
40. Busch TL, Fried LP, Barrett-Connor E Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 1988; 34: B60-B70
41. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986; 256: 2835-2838
42. Isles CG, Hole DJ, Gillis CR, Hawthorne VM, Lever AF Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ 1989; 298: 920-924
43. Jacobs DR Jr, Meban IL, Bangdiwala SI, Criqui MH, Tyroler HA High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32-47
44. Livshits G, Weisbort J, Meshulam N, Brunner D Multivariate analysis of the twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study and the usefulness of high density lipoprotein cholesterol percentage. Am J Cardiol 1989; 63: 676-681
45. Barrett-Connor E, Khaw KT, Wingard DL. A ten-year prospective study of coronary heart disease mortality among Rancho Bernardo women. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987:117-21.
46. Higgins M, Keller JB, Ostrander LD. Risk factors for coronary heart disease in women: Tecumseh Community Health Study, 1959-80. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987:83-9.
47. Keil JE, Gazes PC, Loadholt CB, et al. Coronary heart disease mortality and its predictors among Charleston, South Carolina, women. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987:90-8.
48. Tyroler HA, Heyen S, Bartel A, Blood pressure and cholesterol as coronary heart disease risk factors. Arch Intern Med 1971; 128: 907-914
49. Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Coronary heart disease risk factors in women: the Nurses' Health Study experience. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987:112-6.
50. Kannel WB Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114: 413-419
51. Leren P The Oslo Diet-Heart Study: eleven-year report. Circulation 1970; 42: 935-942
52. Bierenbaum ML, Fleischman AI, Raichelson RI, Hayton T, Watson PB Ten-year experience of modified-fat diets on younger men with coronary heart-disease. Lancet 1973; 1: 1404-1407
53. Canner PL, Berge KG, Wenger NK, Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245-1255
54. Burr ML, Fehily AM, Gilbert JF, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and Reinfarction Trial (DART). Lancet 1989; 2: 757-761
55. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-3012
56. Levy RI, Brensike JF, Epstein SE, The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 325-337
57. The Scottish Society of Physicians. Ischaemic heart disease: a secondary prevention trial using clofibrate. BMJ 1971; 790: 775-784
58. Trial of clofibrate in the treatment of ischaemic heart disease: five-year study by a group of physicians of the Newcastle upon Tyne region. BMJ 1971; 790: 767-775
59. Rosenhamer G, Carlson LA Effect of combined clofibrate-nicotinic acid treatment in ischemic heart disease. Atherosclerosis 1980; 37: 129-142
60. Moreno GT, Manson JE Cholesterol and coronary heart disease in women: an overview of primary and secondary prevention. Coron Artery Dis 1993; 4: 580-587
61. Muldoon MF, Manuck SB, Matthews KA Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309-314
62. Kannel WB, McGee D, Gordon T A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976; 38: 46-51
63. Johnson JL, Heineman EF, Heiss G, Hames CG, Tyroler HA Cardiovascular disease risk factors and mortality among black women and white women aged 40-64 years in Evans County, Georgia. Am J Epidemiol 1986; 123: 209-220
64. Sigurdsson JA, Bengtsson C, Lapidus L, Lindquist O, Rafnsson V Morbidity and mortality in relation to blood pressure and antihypertensive treatment: a 12-year follow-up study of a population sample of Swedish women. Acta Med Scand 1984; 215: 313-322
65. Fiebach NH, Hebert PR, Stampfer MJ, A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 1989; 130: 646-654
66. Collins R, Peto R, MacMahon S, Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-838
67. The Management Committee of the Australian National Blood Pressure Study. Prognostic factors in the treatment of mild hypertension. Circulation 1984; 69: 668-676
68. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97-104
69. MRC Working Party Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412
70. Amery A, Birkenhager W, Brixko R, Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986; 2: 589-592
71. Hypertension Detection and Follow-up Program Cooperative Group. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris: 5-year findings of the Hypertension Detection and Follow-up Program. Hypertension 1984; 6: Suppl I: I-198
72. MacMahon S, Peto R, Cutler J, Blood pressure, stroke, and coronary heart disease. I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774
73. Anastos K, Charney P, Charon RA, Hypertension in women: what is really known? The Women's Caucus, working group on women's health of the Society of General Internal Medicine. Ann Intern Med 1991; 115: 287-293
74. Stamler R, Stamler J, Grimm R, Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial -- the Hypertension Control Program. JAMA 1987; 257: 1484-1491
75. Langford HG, Blaufox MD, Oberman A, Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA 1985; 253: 657-664
76. Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase I. JAMA 1992; 267: 1213-1220 [Erratum, JAMA 1992;267:2330.]
77. Complications of pregnancy. In: Hughes EC, ed. Obstetric-gynecologic terminology. Philadelphia: F.A. Davis, 1972:422.
78. Mann JI, Doll R, Thorogood M, Vessey MP, Waters WE Risk factors for myocardial infarction in young women. Br J Prev Soc Med 1976; 30: 94-100
79. Croft P, Hannaford PC Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' Oral Contraception Study. BMJ 1989; 298: 165-168
80. Rosenberg L, Miller DR, Kaufman DW, Myocardial infarction in women under 50 years of age. JAMA 1983; 250: 2801-2806
81. Saltzberg S, Stroh JA, Frishman WH Isolated systolic hypertension in the elderly: pathophysiology and treatment. Med Clin North Am 1988; 72: 523-547
82. Shekelle RB, Ostfeld AM, Klawans HL Jr Hypertension and risk of stroke in an elderly population. Stroke 1974; 5: 71-75
83. Kannel WB. Implications of Framingham study data for treatment of hypertension: impact of other risk factors. In: Laragh JH, Bühler FR, Seldin DW, eds. Frontiers in hypertension research. New York: Springer-Verlag, 1981:17-21.
84. Society of Actuaries, Association of Life Insurance Medical Directors of America. Blood Pressure Study, 1979. Schaumburg, Ill.: Society of Actuaries, 1980.
85. Kannel WB, McGee DL Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035-2038
86. Manson JE, Colditz GA, Stampfer MJ, A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-1147
87. Barrett-Connor E, Wingard DL Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983; 118: 489-496
88. Pan WH, Cedres LB, Liu K, Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123: 504-516
89. Ruderman NB, Haudenschild C Diabetes as an atherogenic factor. Prog Cardiovasc Dis 1984; 26: 373-412
90. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
91. O'Sullivan JB. Workshop 4: subsequent morbidity among gestational diabetic women. In: Sutherland HW, Stowers JM, eds. Carbohydrate metabolism in pregnancy and the newborn. Edinburgh, Scotland: Churchill Livingstone, 1984:174-80.
92. Stowers JM. Workshop 5: follow-up of gestational diabetic mothers treated thereafter. In: Sutherland HW, Stowers JM, eds. Carbohydrate metabolism in pregnancy and the newborn. Edinburgh, Scotland: Churchill Livingstone, 1984:181-3.
93. Mestman JH. Follow-up studies in women with gestational diabetes mellitus: the experience at Los Angeles County/University of Southern California Medical Center. In: Weiss PAM, Coustan DR, eds. Gestational diabetes. Vienna, Austria: Springer-Verlag, 1988:191-8.
94. Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Halter JB, Porte D Jr Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 1985; 34: 861-869
95. Wood PD, Stefanick ML, Williams PT, Haskell WL The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991; 325: 461-466
96. Bjorntorp P Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994-995
97. Harlan LC, Harlan WR, Landis JR, Goldstein NG Factors associated with glucose tolerance in adults in the United States. Am J Epidemiol 1987; 126: 674-684
98. Reichley KB, Mueller WH, Hanis DL, Centralized obesity and cardiovascular disease risk in Mexican Americans. Am J Epidemiol 1987; 125: 373-386
99. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984; 289: 1257-1261
100. Blair D, Habicht JP, Sims EAH, Sylwester D, Abraham S Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol 1984; 119: 526-540
101. Hartz AJ, Rupley DC Jr, Kalkhoff RD, Rimm AA Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med 1983; 12: 351-357
102. Kaplan NM The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520
103. Haffner SM, Katz MS, Dunn JF Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes 1991; 15: 471-478
104. Barrett-Connor E, Khaw KT Cigarette smoking and increased central adiposity. Ann Intern Med 1989; 111: 783-787
105. Kaye SA, Folsom AR, Prineas RJ, Potter JD, Gapstur SM The association of body fat distribution with lifestyle and reproductive factors in a population study of postmenopausal women. Int J Obes 1990; 14: 583-591
106. Rodin J, Radke-Sharpe N, Rebuffe-Scrive M, Greenwood MRC Weight cycling and fat distribution. Int J Obes 1990; 14: 303-310
107. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS Physical activity and the incidence of coronary heart disease. Annu Rev Public Health 1987; 8: 253-287
108. Kannel WB, Sorlie P Some health benefits of physical activity: the Framingham study. Arch Intern Med 1979; 139: 857-861
109. Berlin JA, Colditz GA A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990; 132: 612-628
110. Owens JF, Matthews KA, Wing RR, Kuller LH Physical activity and cardiovascular risk: a cross-sectional study of middle-aged premenopausal women. Prev Med 1990; 19: 147-157
111. Owens JF, Matthews KA, Wing RR, Kuller LH Can physical activity mitigate the effects of aging in middle-aged women? Circulation 1992; 85: 1265-1270
112. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA 1989; 262: 2395-2401
113. Hennekens CH. Alcohol. In: Kaplan NM, Stamler J, eds. Prevention of coronary heart disease: practical management of the risk factors. Philadelphia: W.B. Saunders, 1983:130-8.
114. Rimm ED, Giovannucci EL, Willett WC, Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-468
115. Thornton J, Symes C, Heaton K Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet 1983; 2: 819-822
116. Landolfi R, Steiner M Ethanol raises prostacyclin in vivo and in vitro. Blood 1984; 64: 679-682
117. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994; 272: 929-933
118. Laug WE Ethyl alcohol enhances plasminogen activator secretion by endothelial cells. JAMA 1983; 250: 772-776
119. Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ Alcohol consumption and blood pressure: Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med 1977; 296: 1194-1200
120. Longnecker MP Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994; 5: 73-82
121. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106
122. ISIS-2 (Second International Study of Infarct Survival). Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360
123. Aspirin prophylaxis. In: Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. Baltimore: Williams & Wilkins, 1989:258-60.
124. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987.
125. Women's Health Study Research Group. The Women's Health Study: rationale and background. J Myocard Ischemia 1992; 4: 30-40
126. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924
127. Keaney JF Jr, Gaziano JM, Xu A, Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A 1993; 90: 11880-11884
128. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456
129. Gaziano JM, Manson JE, Branch LG, Dietary beta carotene and decreased cardiovascular mortality in an elderly cohort. J Am Coll Cardiol 1992; 19: Suppl A: 377A-377A abstract.
130. Enstrom JE, Kanim LE, Klein MA Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194-202
131. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH Beta carotene therapy for chronic stable angina. Circulation 1990; 82: Suppl III: III-201 abstract.
132. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035
133. Hennekens CH, Buring JE, Peto R Antioxidant vitamins -- benefits not yet proved. N Engl J Med 1994; 330: 1080-1081
134. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105-1110
135. Stampfer MJ, Colditz GA, Willett WC Menopause and heart disease: a review. Ann N Y Acad Sci 1990; 592: 193-203
136. Heller RF, Jacobs HS Coronary heart disease in relation to age, sex, and the menopause. BMJ 1978; 1: 472-474
137. Bush TL, Miller VT. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In: Mishell DR Jr, ed. Menopause: physiology and pharmacology. Chicago: Year Book, 1987:187-208.
138. Grady D, Rubin SM, Petitti DB, Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-1037
139. Goldman L, Tosteson ANA Uncertainty about postmenopausal estrogen -- time for action, not debate. N Engl J Med 1991; 325: 800-802
140. Nabulsi AA, Folsom AR, White A, Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069-1075
141. Falkeborn M, Persson I, Adami HO, The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992; 99: 821-828
142. Stadel BV Oral contraceptives and cardiovascular disease. N Engl J Med 1981; 305: 672-677
143. Hennekens CH, Evans D, Peto R Oral contraceptive use, cigarette smoking, and myocardial infarction. Br J Fam Plann 1979; 5: 66-67
144. Mann JI, Vessey MP, Thorogood M, Doll SR Myocardial infarction in young women with special reference to oral contraceptive practice. BMJ 1975; 2: 241-245
145. Thorogood M Oral contraceptives and cardiovascular disease: an epidemiologic overview. Pharmacoepidemiol Drug Saf 1993; 2: 3-16
146. Stolley PD Epidemiologic studies of coronary heart disease: two approaches. Am J Epidemiol 1980; 112: 217-224
147. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health Study. Am J Obstet Gynecol 1990; 163: 285-291